Dementia-related risk associated with endocrine and targeted therapy strategies in breast cancer: a real-world pharmacovigilance analysis.

Cui R, Yin Y, Chen H

Open source

DOI
10.3389/fphar.2026.1855112
Published
2026
Container
Frontiers in pharmacology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1855112,
  title = {Dementia-related risk associated with endocrine and targeted therapy strategies in breast cancer: a real-world pharmacovigilance analysis.},
  author = {Cui R and Yin Y and Chen H},
  year = {2026},
  journal = {Frontiers in pharmacology},
  doi = {10.3389/fphar.2026.1855112},
  url = {https://doi.org/10.3389/fphar.2026.1855112}
}

RIS

TY  - JOUR
TI  - Dementia-related risk associated with endocrine and targeted therapy strategies in breast cancer: a real-world pharmacovigilance analysis.
AU  - Cui R
AU  - Yin Y
AU  - Chen H
PY  - 2026
JO  - Frontiers in pharmacology
DO  - 10.3389/fphar.2026.1855112
UR  - https://doi.org/10.3389/fphar.2026.1855112
ER  - 

APA

R, C., Y, Y., & H, C. (2026). Dementia-related risk associated with endocrine and targeted therapy strategies in breast cancer: a real-world pharmacovigilance analysis.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2026.1855112

Source records